MACROH2A1 and neuroblastoma: Utilizing genome-wide CRISPR/Cas9 screens in a human coculture assay, we revealed the previously undescribed function of epigenetic regulator H2AFY as a resistance mechanism to PD-1 blockade in high-risk NB.